Repatha 140 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26F8E6F
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,468
Award facts
- Contract value 100% obligated
- $12,467.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 22, 2026, the Defense Logistics Agency (DLA) awarded a delivery order valued at $12,467.95 to Amerisourcebergen Drug Corp for the supply of Repatha 140 mg/ml SureClick auto-injectors. The contract carries a firm fixed price structure with no set-aside designation, indicating competitive award. This delivery order is executed under Amerisourcebergen Drug Corp's parent company, Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2031. The pharmaceutical will be delivered to the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of January 23, 2026.
This award supports the military healthcare supply chain by delivering Repatha, a prescription medication used for cholesterol management in patients with cardiovascular disease. As a delivery order under the larger DLA IDC vehicle, this transaction exemplifies the comprehensive pharmaceutical procurement approach that supplies military treatment facilities and veteran healthcare programs. Cencora, operating under the Amerisourcebergen name, maintains a critical role as a primary pharmaceutical distributor for federal medical procurement, delivering an extensive portfolio of specialty medications, brand-name and generic drugs, and medical devices across multiple therapeutic domains to support military healthcare operations globally.
Quick answers
Who was awarded contract SPE2DR26F8E6F?
SPE2DR26F8E6F was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26F8E6F worth?
The government has obligated $12,468 on SPE2DR26F8E6F.
Is contract SPE2DR26F8E6F an order under another contract?
Yes. SPE2DR26F8E6F is a delivery order under SPE2DR25D3202, an indefinite delivery contract.
Was contract SPE2DR26F8E6F competed?
The extent of competition for SPE2DR26F8E6F was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award